On November 29, Express Scripts Holding’s (ESRX) stock price closed at $101.22, which is ~5% growth from the close of $96.81 on November 23. Express Scripts Holding’s stock price grew from $74.64 at the close of the market on December 29, 2017, to $101.22 at the close of the market on November 29, which reflects ~36% YTD (year-to-date) growth.
On November 29, Express Scripts Holding’s stock price closed at $101.22, which is ~65% growth from its 52-week low of $61.30 on November 29, 2017. On November 29, Express Scripts Holding hit its 52-week high of $101.71.
Financials in a nutshell
Express Scripts Holding’s net revenues during the first nine months of 2018 were $76.0 billion—compared to $74.7 billion during the same period in 2017. Wall Street analysts expect Express Scripts Holding to report net revenues of $101.9 billion. Anthem (ANTM) reported revenues of $22.98 billion in the third quarter, which reflects 4% YoY growth.
Express Scripts Holding’s net operating income during the first nine months of 2018 amounted to $3.8 billion—compared to $3.9 billion during the same period in 2017.
The company’s net income and diluted EPS during the first nine months of 2018 amounted to $2.6 billion and $4.54, respectively—compared to $2.2 billion and $3.72 during the same period in 2017.
In November, Express Scripts Holdings and myMatrixx announced the launch of mydataSense—a digital analytics tool for patient safety and savings.
Among the 20 analysts tracking Express Scripts Holding in November, five recommended a “strong buy,” while 15 recommended a “hold.” On November 20, Express Scripts Holding had a consensus 12-month target price of $93.37, which represents an ~7.76% decline over the next 12 months.